Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
84 hedge funds and large institutions have $41.2M invested in Accelerate Diagnostics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 8 closing their positions.
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
121% more capital invested
Capital invested by funds: $18.6M → $41.2M (+$22.6M)
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
14% more funds holding
Funds holding: 74 → 84 (+10)
85% less call options, than puts
Call options by funds: $190K | Put options by funds: $1.23M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Griffin Asset Management
New York
|
+$5.5M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.88M |
| 3 |
JP Morgan Chase
New York
|
+$1.77M |
| 4 |
Millennium Management
New York
|
+$1.19M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$862K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.88M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$392K |
| 3 |
CIA
Cladis Investment Advisory
Billings,
Montana
|
-$137K |
| 4 |
E
Ergoteles
New York
|
-$131K |
| 5 |
HF
HRT Financial
New York
|
-$114K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GIA
76
GHP Investment Advisors
Denver,
Colorado
| $2K | – | – | – |
|
|
PMFA
77
Plante Moran Financial Advisors
Southfield,
Michigan
| $2K | – | – | – |
|
78
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $1K | – | – | – |
|
|
SPIA
79
Steward Partners Investment Advisory
New York
| $1K | – | – | – |
|
|
E
80
Ergoteles
New York
| – | -$131K | -13,230 | Closed |
|
|
HF
81
HRT Financial
New York
| – | -$114K | -11,559 | Closed |
|
82
Acadian Asset Management
Boston,
Massachusetts
| – | -$38K | -3,823 | Closed |
|
83
AQR Capital Management
Greenwich,
Connecticut
| – | -$28K | -2,810 | Closed |
|
|
WG
84
Watchman Group
Plano,
Texas
| – | -$20K | -2,000 | Closed |
|
|
VVP
85
Venture Visionary Partners
Sylvania,
Ohio
| – | -$248 | -25 | Closed |
|
|
CCM
86
Covington Capital Management
Los Angeles,
California
| – | +$298 | +18 | New |
|
AXDX Hedge Fund Activity: Q3 2022 in Review
84 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2022, worth a combined $41.2M — up 121% from $18.6M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new AXDX positions and 8 closed out — a net gain of 11 holders — while 16 added to existing stakes and 14 trimmed.
The largest buyer was Griffin Asset Management, adding an estimated $5.5M. The largest seller was Citadel Advisors, cutting an estimated $1.88M.
- 84 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2022, up from 74 in Q2 2022.
- Funds reported $41.2M of Accelerate Diagnostics stock for Q3 2022, up 121% quarter-over-quarter.
- 19 funds opened new Accelerate Diagnostics positions in Q3 2022 and 8 closed out, a net change of +11 holders.
- The largest Accelerate Diagnostics buyer in Q3 2022 was Griffin Asset Management, an estimated $5.5M added.
- The largest Accelerate Diagnostics seller in Q3 2022 was Citadel Advisors, an estimated $1.88M sold.
Based on aggregated 13F filings for Q3 2022.